Last reviewed · How we verify
NCT07281742
Amblyopia Treatment for Children Aged 8 to 12 Years
NA trial testing Curesight dichoptic videos in Amblyopia in 30 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Retina Foundation of the Southwest |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 7 January 2025 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Curesight dichoptic videos
Conditions studied
- Amblyopia — all drugs for Amblyopia →
Sponsor
Retina Foundation of the Southwest
Who can join
Adults 8 to 12, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07281742
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amblyopia
Currently open trials in the same condition.
- NCT07323953 — Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children · NA · recruiting
- NCT07417046 — Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopi · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
- NCT06380517 — Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age · Phase 3 · recruiting
- NCT06712849 — Noninvasive Brain Stimulation in Adult Amblyopia · NA · recruiting
Other Retina Foundation of the Southwest trials
Trials by the same sponsor.
- NCT05440448 — Patch-free Occlusion Therapy · NA · recruiting
- NCT05439200 — Video Treatment for Amblyopia · NA · recruiting
- NCT03825107 — Dichoptic Video Treatment for Amblyopia · NA · completed
- NCT03322930 — Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) · completed
- NCT03288948 — Binocular Amblyopia Treatment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07281742 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Retina Foundation of the Southwest
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07281742.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing